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Abstract We performed comparative proteome analysis of
mesenchymal cells and chondrocytes to identify proteins di¡er-
entially expressed during chondrogenesis. Nine such proteins
were identi¢ed. Type II collagen, matrilin-1, carbonic anhy-
drase-II (CA-II), 3P-phosphoadenosine 5P-phosphosulfate
(PAPS) synthetase-2, and aldo-keto reductase were increased
during chondrogenesis, whereas cellular retinoic acid binding
protein-I (CRABP-I), CRABP-II, cytoplasmic type 5 actin,
and fatty acid binding protein were decreased or almost disap-
peared. Expression of type II collagen, matrilin-1, PAPS syn-
thetase-2, and CA-II was regulated by extracellular signal-regu-
lated protein kinase, protein kinase C, and p38 kinase, signaling
molecules known to regulate chondrogenesis.
/ 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Chondrogenesis is the process by which ectodermal mesen-
chymal cells di¡erentiate into chondrocytes. Chondrogenesis
is a key step in the development of cartilage and bone that
occurs at limb buds during embryonic development. Initially,
mesenchymal cells proliferate, increasing the number of chon-
drogenic competent cells. These cells subsequently undergo
extensive cell-to-cell and cell-to-matrix interactions, leading
to precartilage condensations, which are characterized by
the denser packing of cells in particular regions. These pre-
cartilage condensations di¡erentiate into cartilage nodules, in
which the di¡erentiated chondrocytes are located [1,2]. The
process of chondrogenesis can be mimicked in vitro by cultur-
ing mesenchymal cells derived from limb buds at a high seed-
ing density, such as in micromass culture.
Di¡erentiated chondrocytes synthesize and secrete cartilage-
speci¢c extracellular matrix (ECM) components, such as type
II collagen and sulfated proteoglycan [3^5]. The balanced syn-
thesis and degradation of cartilage-speci¢c ECM molecules by
chondrocytes are important for maintaining cartilage homeo-
stasis, and the breakdown of this homeostasis results in de-
generative diseases, including osteoarthritis and rheumatoid
arthritis [6^8]. In addition, genetic defects in the chondrogenic
pathway can cause many pathological symptoms, including
dwar¢sm, chondrodysplasia, and osteoarthritis [9^11].
Chondrogenesis is regulated by complex protein kinase sig-
naling pathways, which include protein kinase CK (PKCK)
[12,13], extracellular signal-regulated protein kinase-1 (ERK-
1) [14], and p38 mitogen-activated protein (MAP) kinase [15].
PKCK has been shown to positively regulate chondrogenesis
of mesenchymal cells, in that the expression and activity of
PKCK are dramatically increased during chondrogenesis,
whereas the selective inhibition of this enzyme is su⁄cient
to block this process [13,14,16]. The PKCK-dependent regu-
lation of chondrogenesis appears to be exerted by inhibiting
ERK-1 signaling [14]. In contrast, p38 kinase activity is in-
creased during chondrogenesis in a PKCK-independent man-
ner, and inhibition of its activity blocks chondrogenesis [15].
Therefore, the MAP kinase subtypes p38 kinase and ERK-1
oppositely regulate chondrogenesis by acting as positive and
negative regulators, respectively, of this process.
To further elucidate the signaling pathways in chondrogen-
esis, we performed comparative proteome analysis to identify
proteins di¡erentially expressed by mesenchymal cells and
chondrocytes. We identi¢ed nine proteins whose expression
levels were changed more than two-fold. We proceeded to
investigate the upstream signaling molecules for these nine
proteins.
2. Materials and methods
2.1. Reagents
Antibody to type II collagen was purchased from Chemicon (Te-
mecula, CA, USA). PD98059 was purchased from Biomol (Plymouth
Meeting, PA, USA), Go6976 was purchased from Calbiochem (La
Jolla, CA, USA), and SB203580 was obtained from Tocris (Ellisville,
MO, USA). Sequencing-grade modi¢ed trypsin was purchased from
Promega (Madison, WI, USA), and Ham’s F-12 medium was pur-
chased from Gibco-BRL (Grand Island, NY, USA). The ECL detec-
tion system, GelBond PAG¢lm, and Immobiline bu¡ers were pur-
chased from Amersham Pharmacia Biotech (Uppsala, Sweden).
Alcian blue 8GX, collagenase, K-cyano-4-hydrocinnamic acid, dithio-
threitol (DTT), CHAPS, urea, iodoacetamide (IAA), and silver nitrate
were purchased from Sigma (St. Louis, MO, USA).
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2.2. Micromass culture of mesenchymal cells
Mesenchymal cells derived from the distal tips of Hamburger^
Hamilton (HH) 23/24 chicken embryo limb buds of fertilized white
Leghorn chicken eggs were maintained as micromass cultures to in-
duce chondrogenesis as described previously [14,15]. Brie£y, cells, at a
density of 2.0U107/ml in Ham’s F-12 medium containing 10% fetal
bovine serum (FBS), were spotted as 15-Wl drops onto 35-mm or
60-mm culture dishes and incubated for 2 h at 37‡C to allow attach-
ment. Adherent cells were cultured in Ham’s F-12 medium containing
10% FBS, 50 Wg/ml streptomycin, and 50 U/ml penicillin, and, where
indicated, in the presence of PD98059 (10 WM), Go6976 (1 WM), or
SB203580 (10 WM). Chondrogenesis was monitored by Western blot-
ting of type II collagen and by Alcian blue staining of sulfated pro-
teoglycan [14,15].
2.3. Western blot analysis
Whole cell lysates were prepared by extracting proteins in sodium
dodecyl sulfate (SDS)-sample bu¡er (62.5 mM Tris, pH 6.8, 5% mer-
captoethanol, 10% glycerol, 2% SDS, 0.1% bromophenol blue). Pro-
teins were separated by SDS^polyacrylamide gel electrophoresis
(PAGE) [17] and transferred onto nitrocellulose membranes. Mem-
branes were blocked with 5% non-fat milk in Tris-bu¡ered saline
containing 0.1% Tween 20 and incubated sequentially with antibody
to type II collagen and peroxidase-conjugated secondary antibody,
and the proteins were visualized with an ECL detection system.
2.4. Two-dimensional PAGE
Cells were washed three times with ice-cold phosphate-bu¡ered sa-
line, and total cell lysates were prepared by sonication in lysis bu¡er
(9 M urea, 2% CHAPS, 0.8% pharmalyte, 1% DTT). The lysates were
centrifuged at 15 000Ug for 30 min, and the supernatant was collected
and stored at 380‡C until use. Samples were applied to 18 cm long
pH 4^9 IPG strips [18] for 12 h at 10 V using IPGphor. Isoelectric
focusing was performed at 500 V for 1 h and at 1000 V for 1 h, and
the voltage was gradually increased to 8000 V for 1 h. After focusing
at 8000 V for another 4 h, each strip was incubated for 15 min in
50 mM Tris, pH 8.8, 6 M urea, 30% glycerol, 2% SDS, and 1% DTT
and for an additional 15 min in the same solution containing 2.5%
IAA instead of DTT. The equilibrated strip was placed onto a
10^16% gradient polyacrylamide gel, and the gel was electrophoresed
at 120 V in running bu¡er (25 mM Tris, pH 8.8, 192 mM glycine,
0.1% SDS).
2.5. Protein visualization and image analysis
The gels were ¢xed with 40% ethanol, 10% acetic acid for 1 h and
with 5% ethanol, 5% acetic acid for 2 h. The gels were sensitized with
0.5 M sodium acetate, 1% glutaraldehyde for 30 min and stained with
ammonial silver solution (47 mM silver nitrate, 0.33% ammonia,
20 mM sodium hydroxide) for 30 min. Proteins were developed
with a solution of 0.01% citric acid, 0.1% formaldehyde, and the
reaction was stopped with a solution of 5% Tris, 2% acetic acid.
For in-gel digestion, the gels were ¢xed with 50% methanol, 12%
acetic acid, 1.85% formaldehyde for 1 h, and with 50% ethanol for
2 h. The gels were pretreated with 0.02% sodium thiosulfate for 1 min,
and impregnated with 0.2% silver nitrate, 2.8% formaldehyde for
30 min. After rinsing gels with deionized water, proteins were devel-
oped with a solution of 6% sodium carbonate, 1.85% formaldehyde,
and the reaction was stopped with 50% methanol, 12% acetic acid.
All stained gels were scanned using a GS-710 densitometer (Bio-
Rad, Hercules, CA, USA). The digitalized gel images were normalized
and comparatively analyzed using PDQUEST program (v6.1).
2.6. In-gel digestion
Protein spots were excised from the gel and transferred into micro-
centrifuge tubes. The gel pieces were washed twice with deionized/
¢ltered water, 50 mM ammonium bicarbonate, and acetonitrile
(ACN). Reduction and alkylation were carried out with 10 mM
DTT and 55 mM IAA in 100 mM ammonium bicarbonate, respec-
tively. The gels were again washed with 50 mM bicarbonate in 50%
ACN for 30 min, dried thoroughly, and incubated for 16 h at 37‡C in
a solution of 50 ng/Wl trypsin, 50 mM ammonium bicarbonate, 5 mM
CaCl2. Each supernatant was transferred to a new tube, the gel was
incubated with 25 mM ammonium bicarbonate in 50% ACN, and this
supernatant was added to the same tube. The gels were then extracted
twice with 5% formic acid in 50% ACN. All extracts of a gel piece
were pooled and dried in a vacuum centrifuge.
2.7. Mass spectrometry and database search
The dried peptides were resuspended in 0.5% tri£uoroacetic acid
and mixed with matrix solution saturated with K-cyano-4-hydrocin-
namic acid. After drying the mixed sample on a plate, the mass of the
peptide was determined using matrix-assisted laser desorption/ioniza-
tion mass spectrometry (MALDI-MS) (Voyager DE-STR, Applied
Biosystems). Internal calibration was performed with peptides from
trypsin. Monoisotopic mass peaks were collected and applied to data-
bases including Peptident (http://expasy.nhri.org.tw/tools/peptident.
html) and MS-¢t (http://prospector.ucsf.edu/uscfhtml3.4/ms¢t.htm)
to identify the corresponding protein spots on 2D gels.
3. Results and discussions
3.1. Proteins di¡erentially expressed in mesenchymal cells and
chondrocytes
Chondrogenesis may be accompanied by a coordinated
change of protein expression. To systematically determine
the molecular mechanisms associated with chondrogenesis,
we attempted to identify and characterize the proteins di¡er-
entially expressed during this process. We therefore obtained
mesenchymal cells from chick embryos of HH stage 23/24 by
cutting the tip of the limb buds and spotting the cells onto
plates. The cells di¡erentiated into chondrocytes within 5 days
as demonstrated by the accumulation of sulfated proteoglycan
(Fig. 1A) and expression of type II collagen (Fig. 1B). When
total proteins extracted from undi¡erentiated mesenchymal
cells (day 1 cultures) and di¡erentiated chondrocytes (day 5
cultures) were separated by 2D-PAGE, more than 2000 pro-
tein spots could be visualized by silver staining (Fig. 2A,B).
We attempted to identify proteins di¡erentially expressed
more than two-fold in ¢ve independent experiments by pep-
tide mass ¢ngerprinting (PMF). Selected protein spots were
excised from the gels, and the proteins were digested with
trypsin. The peptides recovered from each protein spot were
subjected to MALDI-MS. A database search, ¢rst of Gallus
gallus proteins, and subsequently of proteins of other species,
was used to identify the proteins. We identi¢ed nine proteins
by PMF, with mass tolerances of 5^30 ppm and coverage of
5^76% (Fig. 2C, Table 1). Expression of ¢ve of these proteins
^ type II collagen, matrilin-1, carbonic anhydrase II (CA-II),
aldo-keto reductase (AKR), and 3P-phosphoadenosine 5P-
phosphosulfate (PAPS) synthetase-2 ^ was increased or newly
appeared during chondrogenesis. In contrast, expression of
Fig. 1. Di¡erentiation of mesenchymal cells into chondrocytes dur-
ing in vitro micromass culture. Prechondrogenic mesenchymal cells
were obtained from chick embryos of HH stage 23/24 by cutting
the tip of the limb buds and spotting them on plates at a density of
2U107 cells/ml. A: Day 1 and day 5 cultured cells stained with Al-
cian blue. B: Total proteins from day 1 and day 5 cultured cells
were separated by 7.5% 1D SDS^PAGE, transferred to nitrocellu-
lose membranes and immunoblotted with antibody to type II colla-
gen. ERK-1 was detected by immunoblotting as a loading control.
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four other proteins ^ fatty acid binding protein (FABP), cy-
toplasmic type 5 actin, cellular retinoic acid binding protein I
(CRABP-I), and CRABP-II ^ decreased or almost disap-
peared in di¡erentiated chondrocytes. Four protein spots
were also identi¢ed by PMF as reference proteins: L-actin,
phosphoglycerate mutase-I, glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH), and nucleoside diphosphate kinase
(Fig. 2A,B).
Of the ¢ve proteins increased or newly appearing in chon-
drocytes, four ^ type II collagen, matrilin-1, PAPS synthetase-
2, and CA-II ^ were related to chondrocyte-speci¢c ECM
organization. Type II collagen, a biomarker of chondrocytes,
was detected as a horizontal streak between pH 7 and pH 8,
with an apparent molecular weight of 165 kDa, a pattern
similar to that in bovine chondrocytes [19]. Matrilin-1, anoth-
er cartilage matrix protein, is one of the most abundant non-
collagenous ¢brillar glycoproteins in cartilage matrix. This
protein has been detected in several types of cartilage, includ-
ing articular cartilage and growth plate [20,21]. Although ma-
trilin-1 knockout mice could survive, they had abnormalities
in type II collagen ¢brillogenesis and ¢bril organization in the
matrix of the maturation zone [22]. CA-II is an enzyme that
catalyzes the hydration and dehydration of carbon dioxide,
making it important for pH balance and the calci¢cation of
cartilage [23]. PAPS synthetase-2 is an enzyme that produces
the sole sulfur donor, PAPS [24]. PAPS synthetase null mice
showed inhibited longitudinal growth, with a narrow range of
the proliferating zone and reduced hypertrophy of chondro-
cytes [25]. Defects in the PAPS synthetase-2 gene result in
many pathological symptoms, including human spondyloepi-
metaphyseal dysplasia and murine brachymorphism [9].
Three of the proteins whose expression is altered in chon-
drocytes ^ CRABP-I, CRABP-II, and AKR ^ are related to
retinoic acid (RA) signaling or metabolism. RA is a potent
regulator of growth plate chondrogenesis [26], and CRABPs
are components of the RA signal pathway [27,28]. CRABP-II
Fig. 2. Proteins di¡erentially expressed during chondrogenesis. A,B: Total proteins from undi¡erentiated mesenchymal cells (day 1) and di¡er-
entiated chondrocytes (day 5) were separated by 2D-PAGE using IPG strips of pH 4^9 and SDS 10^16% gradient gels. C: Comparative analy-
sis of silver-stained gels. Ten protein spots in six di¡erent ¢elds on 2D gels were selected as di¡erentially expressed proteins and identi¢ed by
PMF. Each 2D gel ¢eld is enlarged to more clearly show di¡erential expression of each protein spot. The numbers indicate the corresponding
regions in 2D gels.
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directly channels RA to its receptor, facilitating RA signaling
by translocating it into the nucleus [29,30]. CRABP-I, which is
restricted to the cytosol, functions to sequester RA or to me-
diate its interaction with other metabolizing enzymes [31].
Since RA could induce both CRABPs [31], our ¢nding that
these proteins are down-regulated during chondrogenesis sug-
gests that the concentration of endogenous RA decreases dur-
ing this process. In addition, AKR, which catalyzes the reduc-
tion of retinaldehyde to retinal, can decrease the intracellular
concentration of RA [32]. These ¢ndings indicate that RA
plays a pivotal role in prechondrogenic mesenchymal cells,
but that, during chondrogenesis, the cells gradually escape
from RA signaling.
3.2. Regulatory signaling for the di¡erential expression of
proteins
Because chondrogenesis of mesenchymal cells is regulated
by signaling cascades via various protein kinases, including
ERK-1, PKCK, and p38 kinase, we examined the role of these
kinases in the di¡erential expression of the identi¢ed proteins
using speci¢c inhibitors. Consistent with previous observa-
tions [14,15,33,34], chondrogenesis of mesenchymal cells was
blocked by inhibition of PKCK with Go6976 or inhibition of
p38 kinase with SB203580, whereas inhibition of ERK-1 by
PD98059 enhanced chondrogenesis of mesenchymal cells (Fig.
3). To determine the role of each of these signaling molecules
in the di¡erential expression of proteins during chondrogene-
sis, cells were cultured in the presence of each speci¢c kinase
inhibitor, and the expression levels of the nine identi¢ed pro-
teins were analyzed by 2D-PAGE (Fig. 4). Consistent with
earlier reports [14,15], expression of type II collagen was in-
creased in the presence of the ERK inhibitor PD98059, but
decreased in the presence of the PKCK inhibitor Go6976 or
the p38 kinase inhibitor SB203580 (Fig. 4). Expression of
matrilin-1, PAPS synthetase-2, and CA-II was also increased
by PD98059 and decreased by Go9676 or SB203580, indicat-
ing that these three proteins, as well as type II collagen, are
downstream e¡ector molecules of ERK-1, PKCK, and p38
Table 1
Proteins di¡erentially expressed in mesenchymal cells and chondrocytes
Protein Accession number Observed Mass Expression level
kDa pI vppma %a
Type II collagen Q90W37 165 7.8 19.4 5 New
Matrilin-1 P05099 50 7.7 8.5 11 New
PAPS synthetase-2b O88428 66 7.5 30.1 10 Increase
AKR (1)c Q90W83 36 7.5 11 29 New
AKR (2)c Q90W83 36 7.7 5.4 24 Increase
CA-II P07630 28 6.5 11.2 33 New
Actin, type 5 P53478 43 5.0 27.1 18 Decrease
CRABP-I P40220 14.5 5.3 12.2 76 Decrease
CRABP-IIb P22935 15 5.6 21.6 42 Disappear
FABP P80565 14 5.6 9.4 46 Decrease
avppm, mass accuracy; %, coverage.
bDatabase of mouse was used for PMF.
cTwo di¡erent protein spots in 2D gel: acidic (1) and basic (2) variants.
Fig. 3. Modulation of chondrogenesis by PD98059, Go6976, and SB203580. Mesenchymal cells were maintained as micromass culture for 5
days in the absence or presence of 10 WM PD98059, 1 WM Go6976, or 10 WM SB203580. Accumulated sulfated proteoglycan was visualized by
staining with Alcian blue (A) and quanti¢ed by measuring absorbance of the extracted dye at 600 nm (B). Data from three independent experi-
ments were quanti¢ed and plotted as percentage of control.
FEBS 28210 29-3-04
S.J. Lee et al./FEBS Letters 563 (2004) 35^4038
kinase. It is interesting to notice that the expression levels of
four proteins ^ type II collagen, matrilin-1, PAPS synthetase-
2, and CA-II ^ were uniformly increased and decreased by the
treatment of PD98059 and SB203580, respectively. Since all
four proteins are related to ECM organization of chondro-
cytes, these ¢ndings suggest a possibility that the genes of four
proteins are regulated by the same chondrocyte-speci¢c tran-
scription factor(s) such as Sox5, 6 and 9 [35], which is under
the control of these signaling cascades. Expression of AKR
was not modulated signi¢cantly by treatment with PD98059
or SB203580. The two variants of AKR were di¡erentially
regulated by Go9676, in that expression of the acidic variant
was increased, whereas expression of the basic variant was
decreased.
Protein kinase inhibitors modulated the expression of
CRABP-I, CRABP-II, FABP, and cytoplasmic type 5 actin
di¡erentially. Although it was di⁄cult to determine di¡erences
in expression level of these down-regulated proteins between
control (day 5) and PD98059-treated cells, due to their low
expression in control cells, we nonetheless found that expres-
sion of CRABP-II was reproducibly down-regulated by the
ERK-1 inhibitor PD98059. The PKCK inhibitor Go9676 par-
tially blocked down-regulation of CRABP-II, but it elevated
the expression of CRABP-I more than three-fold compared
Fig. 4. Di¡erential regulation of expression of the identi¢ed proteins by protein kinases. Cells were cultured for 5 days in the presence of
10 WM PD98059, 1 WM Go6976, or 10 WM SB203580. Total protein extracts (80 Wg each) were separated by 2D-PAGE followed by silver stain-
ing. Spots representing the nine identi¢ed proteins from inhibitor-treated cells were compared with those from control cells through three inde-
pendent experiments. The absence of an arrow from the box indicates an undetectable spot on silver-stained gels. Each protein spot was quanti-
¢ed using the PDQUEST program and data from three independent experiments were plotted as percentage of control (right panel). The
intensity of protein spot in day 5 or day 1 culture is used as control (100%) for increased or decreased expression, respectively.
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with day 1 mesenchymal cells. The p38 kinase inhibitor
SB203580 signi¢cantly blocked down-regulation of CRABP-
I and CRABP-II. It is interesting to notice that three proteins
related to the RA signaling cascade ^ CRABP-I, CRABP-II
and AKR ^ showed a partial response to PD98059, Go9676,
and SB203580, which suggests that other signaling cascade(s)
may be involved in the regulation of these RA-related pro-
teins. In contrast, inhibition of the three protein kinases re-
sulted in no noticeable changes in the expression of cytoplas-
mic type 5 actin and FABP. Since there was the discrepancy
between these protein levels and chondrogenic phenotype
(Figs. 2 and 4), and the roles of these proteins in chondro-
genesis are not clear, the observed decrease of cytoplasmic
type 5 actin and FABP may be secondary e¡ects for chondro-
genesis.
Taken together, these results demonstrate that PKCK,
ERK-1, and p38 kinase are major upstream regulators of
chondrogenesis and of proteins di¡erentially expressed during
this process. Our results also showed that expression of some
di¡erentially expressed proteins were not a¡ected by the inhi-
bition of PKCK, ERK-1, or p38 kinase, suggesting the exis-
tence of other signaling or regulatory molecules for the di¡er-
ential expression of these proteins.
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